Cargando…
Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
Treatment of advanced hepatocellular carcinoma remains unsatisfying and so far only prognostic biomarkers like α-fetoprotein have been established. No clear predictive biomarker is currently available for standard of care therapies, including targeted therapies like sorafenib. Novel therapeutic opti...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148424/ https://www.ncbi.nlm.nih.gov/pubmed/30254402 http://dx.doi.org/10.3748/wjg.v24.i35.3974 |